Abstract:The present study investigated the role of the Twist gene in epithelial-mesenchymal transition (EMT) and its effects on the invasion and metastasis of malignant tumors. In vitro, we transfected SW480, HCT116 and HT29 cells with recombinant plasmids, pTracer-CMV/BSD-Twist and pGenesil1.2-Twist-shRNA, to influence expression of Twist. The transfection efficacy of the plasmids in the cell lines was confirmed by flow cytometry. The relative mRNA and protein expression levels of Twist, E-cadherin and vimentin in the transfected cells were detected by RT-PCR and western blotting, respectively. In addition, migration and invasion were assessed by Transwell assays. In vivo, we established a xenogenic liver metastasis mouse model by intrasplenic injection with transfected SW480, HCT116 or HT29 human colon cancer cells and used hematoxylin and eosin (H&E) staining to demonstrate the effective establishment of the model. The relative mRNA levels of Twist and vimentin were detected by RT-PCR. In vitro, RT-PCR and western blotting showed higher relative mRNA and protein expression levels of Twist and vimentin in cell lines transfected with the recombinant, highly expressed Twist plasmid than in non-transfected cell lines (P<0.05), while E-cadherin was inhibited (P<0.05). After transfection with the plasmid pGenesil1.2-Twist-shRNA, the relative mRNA and protein levels of Twist and vimentin were markedly inhibited in the HCT116 cells (P<0.05), and the levels of E-cadherin were not changed (P>0.05), along with inhibition of the migration and invasion abilities of the cell line (P<0.01). In vivo, relative mRNA levels of Twist and vimentin in both the liver and spleen of the mouse model were higher in the groups that were injected with one of the three cell lines transfected with pTracer-CMV/BSD-Twist than in the groups injected with cells transfected with pGenesil1.2-Twist-shRNA (P<0.05). In conclusion, upregulation of Twist gene expression can promote EMT molecular events. Interfering with the Twist gene can effectively silence Twist gene expression in HCT116 cells and consequently inhibit colon cancer cell migration and invasion.

Twist Mediates an Aggressive Phenotype in Human Colorectal Cancer Cells.

AKT-ions with a TWIST between EMT and MET.

Influence of the Twist Gene on the Invasion and Metastasis of Colon Cancer.

Twist: a Molecular Target in Cancer Therapeutics

Twist1 Confers Multidrug Resistance in Colon Cancer Through Upregulation of ATP-binding Cassette Transporters.

Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway

TWIST1 and Cancer

Twist Promotes Reprogramming of Glucose Metabolism in Breast Cancer Cells Through PI3K/AKT and P53 Signaling Pathways

Twist1-mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells.

TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance

PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.

Twist Regulation of EMT and Its Clinical Significance in Monitoring Circulating Tumor Cells and Evaluating Effects of Anticancer Drugs

ZEB1 Promotes Oxaliplatin Resistance Through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells

Targeting Twist Expression with Small Molecules

Mir-181A-twist1 Pathway in the Chemoresistance of Tongue Squamous Cell Carcinoma.

Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms

Retracted: Cxcl12/Cxcr4 Axis Upregulates Twist to Induce Emt in Human Glioblastoma (retracted Article. See Vol. 54, Pg. 7553, 2017)

Mir-15A-3p and Mir-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis.

MiR-381 Functions As a Tumor Suppressor in Colorectal Cancer by Targeting Twist1

Twist2 Contributes to Breast Cancer Progression by Promoting an Epithelial–mesenchymal Transition and Cancer Stem-Like Cell Self-Renewal

Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers Via Erk and Akt Activation